Literature DB >> 16033608

Systolic and diastolic heart failure are associated with different plasma levels of B-type natriuretic peptide.

T Wei1, C Zeng, L Chen, Q Chen, R Zhao, G Lu, C Lu, L Wang.   

Abstract

Previous studies have found that plasma B-type natriuretic peptide (BNP) is elevated during left ventricular systolic or diastolic dysfunction. It is unclear whether the ventricular systolic and diastolic function is associated with different levels of plasma BNP. Plasma BNP was measured in 149 heart failure patients by a rapid point-of-care assay. The patients were divided into left ventricular diastolic dysfunction (n = 48), left ventricular systolic dysfunction (n = 62) and right ventricular systolic dysfunction group (n = 39). The mean BNP level in the left ventricular diastolic dysfunction, left ventricular systolic dysfunction and right ventricular systolic dysfunction was 115 +/- 80 pg/ml, 516 +/- 445 pg/ml and 345 +/- 184 pg/ml, respectively (p < 0.05). We concluded that ventricular systolic and diastolic dysfunction increases plasma BNP levels to a different extent. Left and right ventricular systolic dysfunction is associated with a higher level of plasma BNP than left ventricular diastolic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16033608     DOI: 10.1111/j.1368-5031.2005.00584.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  6 in total

1.  Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care.

Authors:  A Jan; N F Murphy; C O'Loughlin; M Ledwidge; K McDonald
Journal:  Ir J Med Sci       Date:  2011-03-03       Impact factor: 1.568

2.  [Diastolic heart failure: heart failure with preserved ejection fraction].

Authors:  P Dovjak
Journal:  Z Gerontol Geriatr       Date:  2013-01       Impact factor: 1.281

3.  Relationship between B-type natriuretic peptide serum level, echocardiographic TEI index and the degree of diastolic dysfunction in patients with heart failure with preserved systolic function.

Authors:  Danuta Karasek; Władysław Sinkiewicz; Jan Błażejewski
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

4.  Natriuretic Peptide System Activation in Acute Heart Failure Patients with Diabetes.

Authors:  Filipe M Cunha; Joana Pereira; Pedro Marques; Helena Moreira; Pedro Rodrigues; Maria João Pinto; Patrícia Lourenço; Paulo Bettencourt
Journal:  J Diabetes Res       Date:  2017-08-15       Impact factor: 4.011

5.  Prognostic Value of a Tissue Doppler Index of Systodiastolic Function in Patients with Asymptomatic Heart Failure.

Authors:  Nicola Riccardo Pugliese; Iacopo Fabiani; Salvatore La Carrubba; Scipione Carerj; Lorenzo Conte; Paolo Colonna; Pio Caso; Frank Benedetto; Francesco Antonini-Canterin; Maria Francesca Romano; Rodolfo Citro; Vitantonio Di Bello
Journal:  J Cardiovasc Echogr       Date:  2018 Apr-Jun

6.  Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy.

Authors:  Luis E Echeverría; Sergio Alejandro Gómez-Ochoa; Lyda Z Rojas; Karen Andrea García-Rueda; Pedro López-Aldana; Taulant Muka; Carlos A Morillo
Journal:  Front Cardiovasc Med       Date:  2021-11-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.